Clinical implementation of PLANET® Dose for dosimetric assessment after [177Lu]Lu-DOTA-TATE: comparison with Dosimetry Toolkit® and OLINDA/EXM® V1.0

dc.creator	Santoro, Lore
dc.creator	Pitalot, Laurine
dc.creator	Trauchessec, Dorian
dc.creator	Mora Ramírez, Erick
dc.creator	Kotzki, Pierre-Olivier
dc.creator	Bardiès, Manuel
dc.creator	Deshayes, Emmanuel
dc.date.accessioned	2023-01-13T17:17:40Z
dc.date.available	2023-01-13T17:17:40Z
dc.date.issued	2021
dc.description.abstract	The aim of this study was to compare a commercial dosimetry workstation (PLANET® Dose) and the dosimetry approach (GE Dosimetry Toolkit® and OLINDA/EXM® V1.0) currently used in our department for quantification of the absorbed dose (AD) to organs at risk after peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE.	es_ES
dc.description.procedence	UCR::Vicerrectoría de Investigación::Unidades de Investigación::Ciencias Básicas::Centro de Investigación en Ciencias Atómicas Nucleares y Moleculares (CICANUM)	es_ES
dc.identifier.doi	10.1186/s13550-020-00737-8
dc.identifier.issn	2191-219X
dc.identifier.uri	https://hdl.handle.net/10669/88066
dc.language.iso	eng	es_ES
dc.rights	acceso abierto
dc.rights.uri	http://creativecommons.org/publicdomain/zero/1.0/	*
dc.source	EJNMMI Research. 2021 11, 1	es_ES
dc.subject	Dosimetry workstation	es_ES
dc.subject	Peptide receptor radionuclide therapy	es_ES
dc.subject	3D calibration factor	es_ES
dc.subject	Voxel-based dosimetry	es_ES
dc.title	Clinical implementation of PLANET® Dose for dosimetric assessment after [177Lu]Lu-DOTA-TATE: comparison with Dosimetry Toolkit® and OLINDA/EXM® V1.0	es_ES
dc.type	artículo original	es_ES

Files

Now showing 1 - 1 of 1